References
- 1. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Eng J Med. 1981; 304: 1135.10.1056/NEJM1981050730419047012619
- 2. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Eng J Med. 2002; 346: 995-1008.10.1056/NEJMra01050111919310
- 3. Satoh T, Pandey JP, Okazaki Y et al. Single nucleotide polymorphisms of the inflammatory cytokine genes in adults with chronic immune thrombocytopenic purpura. Br J Haematol. 2004; 124: 796-801.10.1111/j.1365-2141.2004.04843.x15009068
- 4. Foster CB, et al. Polymorphisms in inflammatory cytokines and Fcγ receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. Br J Haematol. 2001; 1134: 596-599.10.1046/j.1365-2141.2001.02807.x11380443
- 5. Rocha AM, DeSouza C, Rocha GA, De Mello FF, Saraiva IS, Clementino NC, Marino MC, Queiroz DM. IL1RN VNTR and IL2-330 polymorphic genes are independently associated with chronic immune thrombocytopenia. Br J Haematolol. 2010; 150: 679-84.10.1111/j.1365-2141.2010.08318.x20626741
- 6. Zhao H, Du W, Gu D, Wang D, Xue F, Ge J, Sui T, Yang R. DNMT3B 579G>T promoter polymorphism and the risk for idiopathic thrombocytopenic purpura in a Chinese population. Acta Haematol. 2009; 122: 31-5.10.1159/00023561619696477
- 7. Breunis WB, van Mirre E, Bruin M, Geissler J, Boer M, Peters M, Roos D, Haas M, Koene HR, Kuijpers TW. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood. 2008; 111: 1029-1038.10.1182/blood-2007-03-07991317827395
- 8. Pavkovic M, Georgievski B, Cevreska L, Spiroski M, Efremov DG. CTLA-4 Exon 1 Polymorphism in patients with autoimmune blood disorders. Am J Hematol. 2003; 72: 147-9.10.1002/ajh.1027812555221
- 9. Li H, Ge J, Zhao H, Du W, Xu J, Sui T, Ma L, Zhou Z, Qi A, Yang R. Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with idiopathic thrombocytopenic purpura in a Chinese population. Platelets. 2011; 22: 37-42.10.3109/09537104.2010.52160121034161
- 10. Kuwana M, Kaburaki J, Pandey JP, Murata M, Kawakami Y, Inoko H, Ikeda Y. HLA class II alleles in Japanese patients with immune thrombocytopenic purpura. Associations with antiplatelet glycoprotein autoantibodies and responses to splenectomy. Tissue Antigens. 2000; 56: 337-343.10.1034/j.1399-0039.2000.560405.x11098933
- 11. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998; 352: 878.10.1016/S0140-6736(05)60004-9
- 12. Kuwana M, Ikeda Y. Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies. Int J Hematol. 2006; 84: 309-15.10.1532/IJH97.06188
- 13. Satoh T, Pandey JP, Okazaki Y, et al. Single nucleotide polymorphisms of interleukin-1β associated with Helicobacter pylori infection in immune thrombocytopenic purpura. Tissue Antigens. 2009; 73: 353-357.10.1111/j.1399-0039.2009.01214.x
- 14. George JE, Woolf SH, Raskob GE, Wasser JS, Alderot LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Oker-bloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenic purpura:a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88: 3-40.10.1182/blood.V88.1.3.3
- 15. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009; 113: 2386-2393.10.1182/blood-2008-07-162503
- 16. Giovine FS, Takhsh E, Blakemore AIF, Duff GW. Single base polymorphism at -511 in the human interleukine-1β gene (IL1β). Hum Mol Genetics. 1992; 1: 450.10.1093/hmg/1.6.450
- 17. Lee EB, Kim JY, Lee YJ, Park MH, Song YW. TNF and TNF receptor polymorphisms in Korean Be-chet’s disease patients. Hum Immunol. 2003; 64: 614-620.10.1016/S0198-8859(03)00057-0
- 18. Kornman KS, Crane A, Wang HY, di Giovani FS, Newman MG, Pirk FW, Wilson TG., Higginbottom FL, Duff GW. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontal. 1997; 24: 72-77.10.1111/j.1600-051X.1997.tb01187.x
- 19. Bettinotti MP, Hartung K, Deicher H, et al. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics. 1993; 37: 449-45410.1007/BF002224698436420
- 20. Badenhoop, Schwarz G, Schleusener H, et al. Tumor necrosis factor beta gene polymorphisms in Graves’ disease. J Clin End Metab. 1992; 74: 287-291.
- 21. Vandevyver C, Raus P, Stinisen P, et al. Polymorphism of the tumor necrosis factor beta gene in multiple sclerosis and rheumatoid arthritis. Eur J Immunogenet. 1994; 21: 377-382.10.1111/j.1744-313X.1994.tb00208.x
- 22. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991; 173: 209-219.10.1084/jem.173.1.20921187571670638
- 23. Moffatt MF, Cookson WO. Tumor necrosis factor haplotypes and asthma. Hum Mol Genet 1997; 6: 551-554.10.1093/hmg/6.4.5519097957
- 24. Kehrl JH, Alvarez-Mon M, Delsing GA, Fauci AS. Lymphotoxin is an important T cellderived growth factor for human B cell. Science. 1987; 238: 114-1146.10.1126/science.35005123500512
- 25. Steffen M, Ottmann OG, Moore MA. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. J Immunol. 1988; 140: 2621-2624. 10.4049/jimmunol.140.8.2621